Quantifying Renal Allograft Loss following Early Antibody-Mediated Rejection

Unlike antibody-mediated rejection (AMR) with clinical features, it remains unclear whether subclinical AMR should be treated, as its effect on allograft loss is unknown. It is also uncertain if AMR’s effect is homogeneous across donor (deceased/live) and (HLA/ABO) antibody types. We compared 219 pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transplant
Main Authors: Orandi, Babak J., Chow, Eric H. K., Hsu, Annie, Gupta, Natasha, Van Arendonk, Kyle J., Garonzik-Wang, Jacqueline M., Montgomery, John R., Wickliffe, Corey, Lonze, Bonnie E., Bagnasco, Serena M., Alachkar, Nada, Kraus, Edward S., Jackson, Annette M., Montgomery, Robert A., Segev, Dorry L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304875/
https://ncbi.nlm.nih.gov/pubmed/25611786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.12982
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados